D019656DisordersPhysiologyG05.365.590.029.530440.995929Loss of HeterozygosityFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson11091923Tockman MS, Mulshine JLChest surgery clinics of North AmericaThe early detection of occult lung cancer. Chest Surg Clin N Am. 2000 Nov; 10(4):737-49.Chest Surg Clin N Am2000-11-01T00:00:002000The early detection of occult lung cancer.19011763Mikkelsen T, Doyle T, Anderson J, Margolis J, Paleologos N, Gutierrez J, Croteau D, Hasselbach L, Avedissian R, Schultz LJournal of neuro-oncologyTemozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. J Neurooncol. 2009 Mar; 92(1):57-63.J Neurooncol2008-11-15T00:00:002008Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma.LeiDuanLei Duan349250Duan, LeiAssistant ProfessorCarlMakiCarl Maki349531Maki, CarlProfessorJeffreyBorgiaJeffrey A. Borgia349549Borgia, JeffreyAssociate Professor6Assistant Professor5Associate Professor4Professortrue1ProfessorProfessor27022024Perez RE, Shen H, Duan L, Kim RH, Kim T, Park NH, Maki CGThe Journal of biological chemistryModeling the Etiology of p53-mutated Cancer Cells. J Biol Chem. 2016 May 06; 291(19):10131-47.J Biol Chem2016-03-28T00:00:002016Modeling the Etiology of p53-mutated Cancer Cells.19231157Messahel B, Williams R, Ridolfi A, A'hern R, Warren W, Tinworth L, Hobson R, Al-Saadi R, Whyman G, Brundler MA, Kelsey A, Sebire N, Jones C, Vujanic G, Pritchard-Jones KEuropean journal of cancer (Oxford, England : 1990)Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study. Eur J Cancer. 2009 Mar; 45(5):819-26.Eur J Cancer2009-02-21T00:00:002009Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.0.5720110.04916584research area of0.5743490.04936685subject area forInternal MedicineAnatomy and Cell BiologyRush University, Rush Medical CollegeJamesMulshineJames L. Mulshine41.87328300000000-87.66936330000000349025Mulshine, James0000-0002-4648-9177Professor34320344Larsen BM, Kannan M, Langer LF, Leibowitz BD, Bentaieb A, Cancino A, Dolgalev I, Drummond BE, Dry JR, Ho CS, Khullar G, Krantz BA, Mapes B, McKinnon KE, Metti J, Perera JF, Rand TA, Sanchez-Freire V, Shaxted JM, Stein MM, Streit MA, Tan YC, Zhang Y, Zhao E, Venkataraman J, Stumpe MC, Borgia JA, Masood A, Catenacci DVT, Mathews JV, Gursel DB, Wei JJ, Welling TH, Simeone DM, White KP, Khan AA, Igartua C, Salahudeen AACell reportsA pan-cancer organoid platform for precision medicine. Cell Rep. 2021 07 27; 36(4):109429.Cell Rep2021-07-27T00:00:002021A pan-cancer organoid platform for precision medicine.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor